- Home
- MNDY vs BRKR Comparison
MNDY vs BRKR Comparison
Compare MNDY & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNDY | BRKR |
|---|---|---|
| Founded | 2012 | 1960 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 5.6B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MNDY | BRKR |
|---|---|---|
| Price | $78.03 | $36.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | ★ $174.92 | $49.54 |
| AVG Volume (30 Days) | ★ 3.6M | 2.3M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $21.02 | $6.27 |
| Revenue Next Year | $17.04 | $3.78 |
| P/E Ratio | $34.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.68 | $28.53 |
| 52 Week High | $316.98 | $56.22 |
Technical Indicators
Market Signals| Indicator | MNDY | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 33.91 |
| Support Level | $68.80 | $35.41 |
| Resistance Level | $79.30 | $37.64 |
| Average True Range (ATR) | 4.06 | 1.52 |
| MACD | 2.94 | 0.00 |
| Stochastic Oscillator | 70.73 | 12.23 |
Price Performance
Historical ComparisonAbout MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.